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Purpose: To synthesize and characterize novel trihydroxy benzamido azetidin-2-one derivatives and 
screen them for antimicrobial and antitubercular activities. 
Methods: A series of novel 4-aryl-3-chloro-N-(3,4,5-trihydroxy benzamido)-2-azetidinones, 3a-o, were 
synthesized by reacting various Schiff bases of galloyl hydrazide, 2a-o, with chloroacetyl chloride in the 
presence of dioxan and triethylamine. Schiff bases of galloyl hydrazide, 2a-o, were synthesized from 
galloyl hydrazide. The newly synthesized compounds were characterized by infrared spectroscopy (IR), 
mass spectroscopy (MS) and proton nuclear magnetic spectroscopy (
1
H NMR) and elemental analysis; 
they were also screened for in vitro antibacterial, antifungal and antitubercular activities. Ciprofloxacin 
and ketoconazole were used as reference standards for antibacterial and antifungal activities, 
respectively, while isoniazid was used as reference standard for antitubercular activity. 
Results: Compounds 3f, 3g and 3o with chlorophenyl group and compound 3k with 4-dimethyl amino 
phenyl group exhibited good antimicrobial activity. Also, compounds 3f, 3g, 3k and 3o showed 
antitubercular activity with minimum inhibitory concentration (MIC)  values equivalent to the standard 
drug (isoniazid). MIC values of 3f, 3g, 3k and 3o were 0.76, 0.57.0.62 and 0.83 µg/ml, respectively, 
while the MIC of isoniazid was 0.56.  
Conclusion: We report the successful synthesis, spectral characterization, as well as in vitro 
antimicrobial and antitubercular evaluation of a series of novel trihydroxy benzamido azetidin-2-one 
derivatives. The work shows the emergence of new antimicrobial and antitubercular compounds.  
 
 










*Corresponding author: Email ilangok67@gmail.com, Tel: +91-44-27453160; Fax: +91-44-27455717 
 
  
Ilango & Arunkumar  
Trop J Pharm Res, April 2011;10 (2): 220 
INTRODUCTION 
 
Tuberculosis, one of the most common 
infections, is caused by Mycobacterium 
tuberculosis. According to the World Health 
Organization (WHO), nearly one third of the 
world's population has been exposed to the 
tuberculosis pathogen [1]. Annually, 8 million 
people become ill with tuberculosis and 2 
million people die from the disease 
worldwide. Every 15 seconds, someone dies 
of tuberculosis [2]. There are a number of 
known factors that make people more 
susceptible to tuberculosis infection 
worldwide, the most important of which is 
human immunodeficiency virus (HIV). The 
association of tuberculosis with HIV infection 
is so dramatic that in some cases, nearly two-
third of the patients diagnosed with the 
tuberculosis are also HIV-1 seropositive [3]. 
Smoking more than 20 cigarettes a day also 
increases the risk of tuberculosis by two- to 
four times [4].  
 
Following the discovery of isoniazid, there 
have been no new classes of antitubercular 
drugs in past 40 years  [5].  Moreover, there 
has been a recent and disturbing increase in 
the number of tubercular cases that are 
caused by organisms which are resistant to 
the first-line drugs such as isoniazid, 
rifampicin, ethambutol, streptomycin and 
pyrazinamide [6]. The Global Alliance for 
Tuberculosis (GATB) drug development was 
established to address this need [7]. Its top 
priority is the development of a new agent 
that will shorten the duration of chemotherapy 
from the current 6 – 8 months to two months 
or less. Also new drugs with activity against 
mycobacterium drug-resistant tuberculosis 
and latent tuberculosis are needed.  
 
The addition of a beta-lactamase inhibitor to 
amoxicillin greatly improves its in vitro activity 
against M. tuberculosis [8]. Gallic acid is a 
naturally existing antioxidant [9] which occurs 
along with tannins in most plant species. It 
possesses various biological activities such 
as analgesic [10], antimicrobial [11], 
antineoplastic [12] and antityrosinase [13].  
 
Azetidinone is chemically 2-
Azacyclobutanone which is an integral part of 
penicillin. Ezetimibe, an azetidinone, 
represents the first new approach to lipid 
lowering therapy in more than a decade [14]. 
Moreover, this heterocycle is associated with 
muscle relaxant [15], antitubercular [16] and 
antiinflammatory [17] activities. Considering 
the above pharmacological activities of both 
gallic acid and azetidinones we thought that it 
would be worthwhile to incorporate the 
azetidinone ring into gallic acid to have 






Reactions were monitored by thin layer 
chromatography (TLC) on precoated silica 
gel plates obtained from E. Merck and Co. 
Melting points were determined using Veego 
digital melting point apparatus and are 
uncorrected. IR spectra were recorded on a 
Perkin Elmer FTIR Spectrometer. 
1
H NMR 
spectra were measured with a Bruker 
Spectrometer [400 MHz] in CDCl3 using 
tetramethylsilane (TMS) TMS as an internal 
standard. Mass spectra were obtained with 
LC-MSD Trap- SL 2010A Shimadzu. 
Elemental analysis was determined on a 




All the chemicals used were of analytical 
reagent grade and obtained from Ranbaxy 
Fine Chemicals Ltd, India. Muller-Hinton and 
Sabouraud dextrose agars were obtained 
from Hi-Media Ltd, India. The bacterial strains 
were provided by School of Biotechnology, 
SRM University, Kattankulathur, India. 
Ciprofloxacin and ketaconazole were 
obtained from M/S Orchid Chemicals and 
Pharmaceuticals Limited, Chennai, India. 
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All the compounds were synthesized 
according to the scheme shown in Figure 1. 
The purity of the compounds was determined 
on TLC plates using silica gel G as a 
stationary phase and iodine vapors as 
visualizing agent. 
 
Synthesis of 3,4,5-trihydroxy benzoic acid 
hydrazide from propyl gallate (1a)  
 
Propyl gallate (0.01 mol) in ethanol and 
hydrazine hydrate (0.01 mol) were refluxed 
for 6 h. The excess of solvent was distilled off 
under reduced pressure using a vacuum 
pump. The cold residual mass was washed 
with distilled water, filtered and dried. The 
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crude product obtained was recrystallised 
from methanol to yield galloyl hydrazide 1a. 
Yield: 85 %, Colour: Pale white, Rf value: 
0.61, Mp: 167 ˚C. 
 
General procedure for synthesis of N-
substituted arylidene galloyl hydrazide 
(2a-o) 
 
Equimolar quantities of galloyl hydrazide 1a 
and various aromatic aldehydes in ethanol 
were refluxed for 6 h. The completion of 
reaction was monitored on silica gel G 
precoated TLC plates using hexane and ethyl 
acetate (1:1) as an eluent and observed 
under UV light. The resultant mixture was 
poured into ice cold water. The crude Schiff 
bases were washed, filtered, dried and 
recrystallised from ethanol.  
 
N’--benzylidene galloyl hydrazide (2a): 
Yield: 73 %, Colour: Pale white, Rf value: 
0.61,M.p.; 170-172 ºC. IR (KBr in cm
-1
): 3407 
(NH Str); 3313 (Ar-OH Str); 2987 (Ar-CH Str);  
1693 (C=O Str); 1480 (C=N Str); 1446 (CO-
NH Str). 
1
H NMR (DMSO, δ ppm): 8.35 (s, 
1H, CH=N), 7.28-7.95 (m, 7H, Ar-H), 4.34 (s, 







hydrazide (2b): Yield: 65%, Colour: Pale 
yellow, Rf value: 0.61, M.p.; 168-169 ºC. IR 
(KBr in cm
-1
): 3411 (NH Str); 3332 (Ar-OH 
Str); 2971 (Ar-CH Str);  1675 (C=O Str); 1476 
(C=N Str); 1438 (CO-NH Str).  
1
H NMR 
(DMSO, δ ppm): 8.37 (s, 1H, CH=N), 6.96-








galloyl hydrazide (2c): Yield: 77 %, Colour: 
Pale white, Rf value: 0.61, M.p.; 171-172 ºC. 
IR (KBr in cm
-1
): 3331 (NH Str); 3310 (Ar-OH 
Str); 2994 (Ar-CH Str);  1678 (C=O Str); 1480 
(C=N Str); 1444(CO-NH Str);  1264 (C-O-C 
Str). 
1
H NMR (DMSO, δ ppm): 8.25-9.12 (m, 
5H, Ar-H), 8.41 (s, 1H, CH=N), 4.98 (s, 1H, 








hydrazide (2d): Yield: 79 % , Colour: Pale 
brown, Rf value: 0.61, M.p.; 170-171 ºC. IR 
(KBr in cm
-1
): 3334 (NH Str); 3312 (Ar-OH 
Str); 2981 (Ar-CH Str);  1672 (C=O Str); 1470 
(C=N Str); 1442 (CO-NH Str).  
1
H NMR 
(DMSO, δ ppm): 8.91-9.52 (m, 6H, Ar-H), 








hydrazide (2e): Yield: 82 %, Colour: Pale 
white, Rf value: 0.61, M.p.; 172-174 ºC. IR 
(KBr in cm
-1
): 3318 (NH Str); 3309 (Ar-OH 
Str); 2973 (Ar-CH Str); 1674 (C=O Str); 1476 
(C=N Str); 1438 (CO-NH Str).  
1
H NMR 
(DMSO, δ ppm): 8.48-9.07 (m, 6H, Ar-H), 








hydrazide (2f): Yield: 79 %, Colour: Pale 
white, Rf value: 0.61, M.p.; 168-170 ºC. IR 
(KBr in cm
-1
): 3410 (NH Str); 3304 (Ar-OH 
Str);  2994 (Ar-CH Str); 1758 (C=O Str); 1438 
(C=N Str); 1419 (CO-NH Str);  762 (C-Cl Str). 
1
H NMR (DMSO, δ ppm): 8.54-9.67 (m, 5H, 
Ar-H), 8.36 (s, 1H, CH=N), 7.73 (s, 1H, CH-







hydrazide (2g): Yield: 81 %, Colour: Pale 
yellow, Rf value: 0.61, M.p.; 171-173ºC.  IR 
(KBr in cm
-1
): 3335 (NH Str); 3318 (Ar-OH 
Str); 2983 (Ar-CH Str);  1758 (C=O Str); 1437 
(C=N Str); 1422 (CO-NH Str);  760 (C-Cl Str). 
1
H NMR (DMSO, δ ppm): 8.32 (s, 1H, 
CH=N), 7.48-8.52 (m, 5H, Ar-H), 7.64 (s, 1H, 







benzylidene galloyl hydrazide 
(2h): Yield: 80 %, Colour: Pale brown, Rf 
value:   0.61, M.p.;  170-171ºC.  IR (KBr in 
cm
-1
): 3328 (NH Str); 3302 (Ar-OH Str); 2974 
(Ar-CH Str);  1749 (C=O Str); 1534 (C-NO2 
Str); 1441 (C=N Str); 1421 (CO-NH Str). 
1
H 
NMR (DMSO, δ ppm): 7.23-8.51 (m, 6H, Ar-
H), 8.31 (s, 1H, CH=N), 4.49 (s, 1H, NH), 
2.63 (s, 3H, 3(OH)). 
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benzylidene galloyl hydrazide 
(2i): Yield: 72 %, Colour: Pale yellow, Rf 
value: 0.61, M.p.; 171-172ºC. IR (KBr in cm
-
1
): 3400 (NH Str); 3312 (Ar-OH Str); 2971 (Ar-
CH Str); 1685 (C=O Str);  1535 (C-NO2 Str); 
1480 (C=N Str); 1437 (CO-NH Str).  
1
H NMR 
(DMSO, δ ppm): 7.41-8.69 (m, 6H, Ar-H), 







benzylidene galloyl hydrazide 
(2j): Yield: 85 % , Colour: Pale brown, Rf 
value: 0.61, M.p.; 171-172ºC. IR (KBr in cm
-
1
): 3405 (NH Str); 3315 (Ar- OH Str); 2987 
(Ar-CH Str); 1685 (C=O Str); 1538 (C-NO2 
Str); 1480 (C=N Str); 1432 (CO-NH Str). 
1
H 
NMR (DMSO, δ ppm): 8.44-8.91 (m, 6H, Ar-
H), 8.34 (s, 1H, CH=N), 4.52 (s, 1H, NH), 







hydrazide (2k): Yield: 77 %, Colour: Pale 
white, Rf value: 0.61, M.p.; 175-178 ºC. IR 
(KBr in cm
-1
): 3395 (NH Str); 3331 (Ar- OH 
Str); 2997 (Ar-CH Str); 1668 (C=O Str); 1535 
(C-NO2 Str); 1410 (C=N Str); 1441 (CO-NH 
Str).   
1
H NMR (DMSO, δ ppm): 8.31-9.33 (m, 
6H, Ar-H), 8.42 (s, 1H, CH=N), 4.53 (s, 1H, 








hydrazide (2l): Yield: 81 %, Colour: Pale 
yellow, Rf value: 0.61, M.p.; 171-173 ºC. IR 
(KBr in cm
-1
): 3397 (NH Str); 3313 (Ar-OH 
Str); 2977 (Ar-CH Str); 1687 (C=O Str); 1617 
(C-O-C Str); 1480 (C=N Str); 1445 (CO-NH 
Str).  
1
H NMR (DMSO, δ ppm): 8.18-8.85 (m, 
4H, Ar-H), 8.28 (s, 1H, CH=N), 4.89 (s, 1H, 








hydrazide (2m): Yield: 82 %, Colour: Pale 
browm, Rf value: 0.61, M.p.; 168-169ºC. IR 
(KBr in cm
-1
): 3405 (NH Str); 3333 (Ar-OH 
Str); 2987 (Ar-CH Str); 1670 (C=O Str); 1614 
(C-O-C Str); 1475 (C=N Str); 1439 (CO-NH 
Str). 
1
H NMR (DMSO, δ ppm): 8.16-9.12 (m, 
5H, Ar-H), 8.37 (s, 1H, CH=N), 4.71 (s, 1H, 






hydrazide (2n): Yield: 87 %, Colour: Pale 
yellow, Rf value: 0.61, M.p.; 171-173ºC. IR 
(KBr in cm
-1
): 3405 (NH Str); 3333 (Ar-OH 
Str); 2972 (Ar-CH Str); 1670 (C=O Str); 1614 
(C-O-C Str); 1475 (C=N Str); 1433 (CO-NH 
Str). 
1
H NMR (DMSO, δ ppm): 8.54-9.77 (m, 
6H, Ar-H), 8.36 (s, 1H, CH=N), 4.18 (s, 1H, 




benzylidene galloyl hydrazide 
(2o): Yield: 83 %, Colour: Pale white, Rf 
value: 0.61, M.p.; 179 - 181ºC. IR (KBr in cm
-
1
): 3405 (NH Str); 3328 (Ar-OH Str); 2976 (Ar-
CH Str); 1666 (C=O Str); 1624 (C-O-C Str); 
1435 (C=N Str); 1424 (CO-NH Str); 763 (C-Cl 
Str). 
1
H NMR (DMSO, δ ppm): 8.39-8.95 (m, 
5H, Ar-H), 8.36 (s, 1H, CH=N), 7.7 (s, 1H, 
CH-Cl), 4.15 (s, 1H, NH),  2.14 (s, 3H, 
3(OH)). 
 




A mixture of Schiff base (0.002 mol) and 
triethyl amine (0.004 mol) were dissolved in 
1,4-Dioxan (50 ml). To this, well stirred cold 
solution of chloroacetyl chloride (0.004 mol) 
was added drop wise for 20 min, then stirred 
for further 3 h and left at room temperature 
for 48 h [18]. The resultant mixture was 
concentrated, cooled and then poured into 
ice cold water filtered off, dried and 
recrystalised from methanol.  
 
(3R, 4S)-3-Chloro-4-(phenyl)-N-(-3,4,5-
trihydroxy benzamido)-2-azetidinone (3a):  
Yield: 70 %, Colour: Dull white, Rf value: 
0.63, M.p.; 221˚C. Anal. calcd.for  
C16H13ClN2O5 (348): C, 55.10; H, 3.76; N, 
8.03 %. Found: C, 55.17; H, 3.68; N, 7.98 %.  
IR (KBr in cm
-1
): 3613 (Ar-OH Str); 3467 (NH 
Str); 2977 (Ar-CH Str); 1744 (C=O Str); 1648 
(CO-NH Str); 1474 (CH-N Str); 1446 (CO-NH 
Str); 759 (C-Cl Str). 
1
H NMR (DMSO, δ ppm): 
7.7 (s, 1H, CH-Cl), 7.08- 7.44 (m, 7H, Ar-H), 
Ilango & Arunkumar  
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5.2 (s, 1H, CH-N), 4.15 (s, 1H, NH), 2.33 (s, 






azetidinone (3b): Yield: 73 %, Colour: Pale 
yellow, Rf value: 0.78, M.p.; 198˚C. Anal. 
calcd.for C16H13ClN2O6 (364): C, 54.34; H, 
7.68; N, 6.67 %. Found: C, 54.32; H,7.65; 
N,6.65%. IR (KBr in cm
-1
): 3613 (Ar-OH Str); 
3467 (NH Str); 2977 (Ar-CH Str); 1755 (C=O 
Str); 1648 (CONH Str); 1474 (CH-N Str); 
1446 (CO-NH Str); 757 (C-Cl Str). 
1
H NMR 
(DMSO, δ ppm): 7.68-8.34 (m, 6H, Ar-H), 
7.65 (s, 1H, CH-Cl), 5.43 (s, 1H, CH-N), 4.75 





(3R, 4S)-3-Chloro-4-(2-hydroxy 3-methoxy 
phenyl)-N-(-3,4,5-trihydroxy benzamido)-2-
azetidinone (3c): Yield: 67%, Colour: White, 
Rf value: 0.72, M.p.; 217 ˚C . Anal. calcd. for 
C17H15ClN2O7 (378): C, 53.39; H, 7.62; N, 
6.23 %. Found: C, 53.37;  H, 7.60;  N, 6.28%. 
IR (KBr in cm
-1
): 3614 (Ar-OH Str); 3458 (NH 
Str); 2985 (Ar-CH Str); 1743 (C=O Str); 1661 
(CONH Str); 1482 (CH-N Str); 1446 (CO-NH 
Str); 1268 (C-O-C Str); 762 (C-Cl Str). 
1
H 
NMR (DMSO, δ ppm): 7.12- 8.44 (m, 5H, Ar-
H), 7.7 (s, 1H, CH-Cl), 5.5 (s, 1H, CH-N), 4.4 
(s, 1H, NH), 3.9 (s, 3H, OCH3), 3.48 (s, 4H, 
4(OH)).  MS (m/z): 379 (M
+1




azetidinone (3d): Yield: 63 %,  Colour: 
White, Rf value: 0.69, M.p.; 206 ˚C.  Anal. 
calcd. for C16H13ClN2O6 (364): C, 54.34; H, 
7.68; N, 6.67%. Found: C, 54.28; H, 7.59; N, 
6.79%. IR (KBr in cm
-1
): 3632 (Ar-OH Str); 
3465 (NH Str); 2977 (Ar-CH Str); 1733 (C=O 
Str); 1667 (CONH Str); 1458 (CH-N Str); 
1446 (CO-NH Str); 752 (C-Cl Str). 
1
H NMR 
(DMSO, δ ppm): 7.52- 8.91 (m, 6H, Ar-H),  
7.48 (s, 1H, CH-Cl), 5.5 (s, 1H, CH-N), 4.4 (s, 







azetidinone (3e): Yield: 64 %, Colour: Pale 
yellow, Rf value: 0.83, M.p.; 228 ˚C.  Anal. 
calcd. for C16H13ClN2O6 (364): C, 54.34; 
H,7.68; N, 6.67%. Found: C, 54.38;  H, 7.65;  
N, 6.69 %.  IR (KBr in cm
-1
): 3609 (Ar-OH 
Str); 3358 (NH Str); 2978 (Ar-CH Str); 1772 
(C=O Str); 1653 (CONH Str); 1483 (CH-N 
Str); 758 (C-Cl Str). 
1
H NMR (DMSO, δ ppm): 
7.08- 8.58 (m, 6H, Ar-H), 7.7 (s, 1H, CH-Cl),  
5.5 (s, 1H, CH-N), 4.4 (s, 1H, NH), 2.78 (s, 






(3f): Yield: 71%, Colour: Light brown, Rf 
value: 0.56, M.p.; 243 ˚C. Anal. calcd. for 
C16H12Cl2N2O5 (383): C, 52.06; H, 7.13;  
N,6.39 %.  Found: C, 52.12; H, 7.21;  N, 
6.58%.  IR (KBr in cm
-1
): 3790 (Ar-OH Str); 
3330 (NH Str); 2972 (Ar-CH Str); 1726 (C=O 
Str); 1591 (CONH Str); 1488 (CH-N Str); 761 
(C-Cl Str). 
1
H NMR (DMSO, δ ppm): 7.12-
8.48 (m, 6H, Ar-H), 7.7 (s, 1H, CH-Cl), 5.3 (s, 
1H, CH-N), 4.8 (s, 1H, NH), 2.83 (s, 3H, 






(3g): Yield: 63 %, Colour: Pale yellow, Rf 
value: 0.41, M.p.; 198 ˚C. Anal. calcd. for 
C16H12Cl2N2O5.(382): C, 52.06; H, 7.13; N, 
6.39%.  Found: C, 52.12; H, 7.21; N, 6.58 %. 
IR ((KBr in cm
-1
): 3790 (Ar-OH Str); 3330 (NH 
Str); 2975 (Ar-CH Str); 1732 (C=O Str); 1592 
(CONH Str); 1479 (CH-N Str); 761 (C-Cl Str). 
1
H NMR (DMSO, δ ppm):7.12-8.48 (m, 6H, 
Ar-H), 7.7 (s, 1H, CH-Cl), 5.3 (s, 1H, CH-N), 







(3h):  Yield: 78 %, Colour: White, Rf value: 
0.49, M.p.; 215 
0
C ; Anal. calcd. for 
C16H12ClN3O7 (393): C, 50.83; H, 6.96; N, 
9.36 %. Found: C, 50.55; H, 6.91; N, 9.29%.  
IR (KBr in cm
-1
): 3790 (Ar-OH Str); 3469 (NH 
Str); 2974 (Ar-CH Str); 1731 (C=O Str); 1598 
(CONH Str); 1547 (C-NO2 Str), 1483 (CH-N 
Str); 752 (C-Cl Str). 
1
H NMR (DMSO, δ 
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Trop J Pharm Res, April 2011;10 (2): 225 
ppm): 7.23-8.51 (m, 6H, Ar-H), 7.11 (s, 1H, 
CH-Cl),  5.63 (s, 1H, CH-N), 4.49 (s, 1H, NH) 






(3i): Yield: 73%, Colour: White, Rf value: 
0.75, M.p.; 224 
0
C.  Anal. calcd. for 
C16H12ClN3O7(393): C, 50.83;  H, 6.96; N, 
9.36 %. Found: C, 50.47; H, 6.83; N, 9.31 %.  
IR (KBr in cm
-1
): 3369 (Ar-OH Str); 3457 (NH 
Str); 2978 (Ar-CH Str); 1745 (C=O Str); 1606 
(CONH Str); 1533 (C-NO2 Str); 1481 (CH-N 
Str); 759 (C-Cl Str). 
1
H NMR (DMSO, δ ppm): 
7.41-8.69 (m, 6H, Ar-H), 7.41 (s, 1H, CH-Cl), 
5.23 (s, 1H, CH-N), 4.52 (s, 1H, NH), 2.56 (s, 






(3j): Yield: 66%, Colour: White, Rf value: 
0.80, M.p.; 231 
0
C. Anal.calcd. for  
C16H12ClN3O7(393): C, 50.83;  H, 6.96; N, 
9.36 %. Found: C, 50.51; H, 6.67; N, 9.20 %.  
IR (KBr in cm
-1
): 3330 (Ar-OH Str); 3462 (NH 
Str); 2976 (Ar-CH Str); 1745 (C=O Str); 1619 
(CONH Str); 1548 (C-NO2 Str); 1477 (CH-N 
Str); 751 (C-Cl Str). 
1
H NMR (DMSO, δ ppm): 
7.42-8.87 (m, 6H, Ar-H),  7.63 (s, 1H, CH-Cl), 
5.55 (s, 1H, CH-N), 4.59 (s, 1H, NH), 2.34 (s, 




(3R, 4S)-3-Chloro-4-(4-dimethyl amino 
phenyl)-N-(-3,4,5-trihydroxy benzamido)-2-
azetidinone (3k): Yield: 61%, Colour: White, 
Rf value: 0.66, M.p.; 234 
0
C. Anal. calcd. for 
C18H18ClN3O5(391): C, 56.43; H, 8.34; N, 
9.40 %. Found:  C, 56.31;  H, 8.26; N, 9.35 
%. IR (KBr in cm
-1
): 3685 (Ar-OH Str); 3340 
(NH Str); 2974 (Ar-CH Str); 1755 (C=O Str); 
1678 (CONH Str); 1472 (CH-N Str); 1301 (N-
CH3 Str); 759 (C-Cl Str). 
1
H NMR (DMSO, δ 
ppm): 7.33-8.78 (m, 6H, Ar-H), 7.32 (s, 1H, 
CH-Cl), 5.57 (s, 1H, CH-N), 4.81 (s, 1H, NH), 






azetidinone (3l): Yield: 69%, Colour: Pale 
brown, Rf value: 0.71, M.p.; 241 
0
C; Anal. 
calcd. for C19H19ClN2O8(438): C, 53.49; H, 
7.75; N, 5.67 %. Found: C, 53.51; H, 7.82; N, 
5.65%. IR (KBr in cm
-1
): 3470 (Ar-OH Str); 
3298 (NH Str); 2973 (Ar-CH Str); 1724 (C=O 
Str); 1643 (CONH Str); 1488 (CH-N Str); 
1258 (Ar-OCH3 Str); 756 (C-Cl Str). 
1
H NMR 
(DMSO, δ ppm): 8.21- 8.78 (m, 4H, Ar-H), 
7.51 (s, 1H, CH-Cl), 5.68 (s, 1H, CH-N), 4.92 
(s, 1H, NH),  3.60 (s, 9H, (OCH3)3), 2.47(s, 






azetidinone (3m):  Yield: 66%, Colour: Pale 
brown, Rf value: 0.81, M.p.; 203 
0
C; Anal. 
calcd. for  C18H17ClN2O7(408):  C, 54.36; H, 
7.82; N, 6.04 %. Found: C, 54.32; H, 7.78; N, 
5.98%. IR (KBr in cm
-1
): 3790 (Ar-OH Str); 
3402 (NH Str); 2977 (Ar-CH Str);  1728 (C=O 
Str); 1648 (CONH Str); 1475 (CH-N Str); 
1256 (Ar-OCH3 Str); 764 (C-Cl Str). 
1
H NMR 
(DMSO, δ ppm) 7.25-8.68 (m, 5H, Ar-H), 7.65 
(s, 1H, CH-Cl), 5.43 (s, 1H, CH-N), 4.41 (s, 
1H, NH), 3.32 (s, 6H, (OCH3)2), 2.21 (s, 3H, 






azetidinone (3n): Yield: 73 %, Colour: Pale 
yellow, Rf value: 0.48, M.p.; 218 
0
C; Anal. 
calcd.for  C17H15ClN2O6(378): C, 55.36; H, 
7.90; N, 6.49 %. Found: C, 55.32; H, 7.88; N, 
6.45%.  IR (KBr in cm
-1
): 3769 (Ar-OH Str); 
3402 (NH Str); 2973 (Ar-CH Str); 1732 (C=O 
Str); 1637 (CONH Str); 1473 (CH-N Str); 
1252 (Ar-OCH3 Str); 750 (C-Cl Str). 
1
H NMR 
(DMSO, δ ppm): 7.25-8.68(m, 6H, Ar-H), 7.52 
(s, 1H, CH-Cl),  5.76 (s, 1H, CH-N), 4.89 (s, 
1H, NH), 3.82 (s, 3H, OCH3), 2.43 (s, 3H, 






(3o): Yield: 72%,  Colour: Pale yellow, Rf 
value: 0.54, M.p.; 204 
0
C; Anal. calcd. for 
C16H12Cl2N2O5 (382): C, 52.06; H, 7.13; N, 
6.39 %. Found: C, 52.02; H, 7.11; N, 6.41%. 
IR (KBr in cm
-1
): 3774 (Ar-OH Str); 3400 (NH 
Str); 2978 (Ar-CH Str);  1721 (C=O Str); 1625 
(CONH Str); 1479 (CH-N Str); 764 (C-Cl Str). 
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1
H NMR (DMSO, δ ppm): 7.57-8.94 (m, 6H, 
Ar-H), 7.15 (s, 1H, CH-Cl), 5.12 (s, 1H, CH-
N), 4.59 (s, 1H, NH), 2.45 (s, 3H, 3(OH)),  MS 
(m/z): 383 (M
+1
).                  
 
Evaluation of antimicrobial activity 
 
The minimum inhibitory concentration (MIC) 
of the test compounds was determined by 
broth dilution method [19,20]. Each of the test 
compounds and the standard drugs were 
dissolved in DMSO at a concentration of 100 
µg/ml. Further dilutions of the test 
compounds and standards in the test medium 
were prepared at concentrations of 50, 25, 
12.5, 6.25, 3.12, 1.56 and 0.78 µg/ml. The 
bacterial strains of Bacillus subtilis, 
Staphylococcus aureus, Streptococcus 
mutans, Escherichia coli, Klebsiella 
pneumonia and Pseudomonas aeruginosa 
were maintained on MHA (Muller-Hinton 
Agar) medium for 24 h at 37 
o
C while fungal 
strains of Candida albicans and Aspergillus 
niger were maintained on PDA (Potato 
Dextrose Agar) medium for 48 h at 25 
o
C. 
The bacterial and fungal suspensions were 
adjusted with sterile water to a concentration 
of approximately 103 CFU/ml and 104 
CFU/ml, respectively. The test compounds 
and standard drugs, ciprofloxacin and 
ketoconazole, at various concentrations, 
were prepared in MHA medium for bacteria 
and PDA medium for fungi by two-fold serial 
dilution method and then inoculated and 
incubated for 24 h at 37 
o
C for bacteria and 
48 h at 25 
o
C for fungi. The last tube with no 
growth of microorganism was recorded as the 
MIC, expressed in µg/ml. 
 
Evaluation of anti-tubercular activity  
 
Antitubercular activity was evaluated against 
Mycobacterium tuberculosis H37 Rv using 
Microplate alamar blue assay (MABA) 
method [21,22]. Antitubercular susceptibility 
test was performed in black, clear-bottomed, 
96-well microplates (Packard Instrument 
Company, Meriden, Conn., USA) in order to 
minimize background fluorescence. Initial 
drug dilutions were prepared in 
dimethylsulfoxide and subsequent two-fold 
dilutions were performed in 0.1 ml of 7H9GC 
media in the microplates. An aliquot (100 µl) 
of 2000CFU/ml of M. tuberculosis H37 Rv 
were added to each well of 96-well microtitre 
plate containing test compounds. Three 
control well plates containing drug and 
medium, bacteria and medium, and medium 
only were also prepared. All microtitre plates 
were incubated at 37 °C for seven days. At 
day 7 of incubation, Alamar Blue dye solution 
(20 µl Alamar Blue solution and 12.5 ml of 20 
% Tween 80) was added to all the wells and 
the plates re-incubated at 37 °C for 24 h. 
Fluorescence was measured in a Victor II 
multilabel fluorometer (Perkin Elmer Life 
Sciences Inc., Boston, MA, USA) and MIC 




The antimicrobial study was a completely 
randomized study with three replications.  
Data were subjected to ANOVA using 
GraphPad Instat (Version 3.01, University of 
Kentucky, GTA-50429-259). A significant 





Physicochemical parameters of the 
synthesized compounds, including color, Rf 
value, and melting point are shown in Table 1 
while antimicrobial and antitubercular results 




Compounds 3f, 3g, 3k and 3o were active, 
among the compounds in the series (3a-o), 
exhibiting antibacterial and antifungal 
activities as high as those of the reference 
standards - ciprofloxacin and ketoconazole, 
respectively. On the other hand, compounds 





Compounds 3f, 3g, 3k and 3o showed MIC 
values equivalent to that of the reference 
standard, isoniazid. Compounds 3a, 3c, 3j  
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Table 1: Physicochemical parameters of the synthesized compounds  
 
Code R Colour Mol.Wt % Yield Melting Pt. Rf.Value 
3a H Dull white 348.1 64 221 0.63 
3b 2-OH Pale yellow 364.7 68 198 0.78 
3c 2-OH-3-OCH3 White 394.7 68 217 0.72 
3d 3-OH White 364.7 62 206 0.69 
3e 4-OH Pale yellow 364.7 72 228 0.83 
3f 2-Cl Light Brown 382.1 71 243 0.56 
3g 3-Cl Pale yellow 382.1 63 211 0.41 
3h 2-NO2 White 393.7 78 215 0.49 
3i 3-NO2 White 393.7 66 224 0.75 
3j 4-NO2 White 393.7 73 231 0.80 
3k 4-N-(CH3)2 White 391.8 61 234 0.66 
3l 3,4,5-(OCH3)3 Pale brown 438.8 69 241 0.71 
3m 3,4,-(OCH3)2 Pale brown 408.7 66 203 0.81 
3n 4-OCH3 Pale yellow 378.7 73 218 0.48 
3o 4-Cl Pale yellow 382.1 72 204 0.54 
 
 
Table 2:  Antimicrobial and antitubercular activities of compounds 3a-o  
 








BS SA SM EC KP PA CA AN MT 
3a - H 12.5 25 25 12.5 25 12.5 12.5 6.25 2.8 
3b - 2-OH 25 12.5 25 25 12.5 25 25 25 50.3 
3c - 2-OH-3-OCH3 6.25 3.12 3.12 1.56 3.12 3.12 6.25 3.12 3.7 
3d - 3-OH 25 25 50 12.5 12.5 12.5 12.5 25 50.3 
3e - 4-OH 12.5 12.5 25 25 50 25 12.5 25 34.2 
3f - 2-Cl 6.25 12.5 3.12 6.25 3.12 6.25 3.12 1.56 0.76 
3g - 3-Cl 1.56 1.56 3.12 6.25 3.12 6.25 1.56 3.12 0.57 
3h - 2-NO2 25 12.5 12.5 25 25 12.5 25 25 17.1 
3i - 3-NO2 6.25 12.5 3.12 12.5 6.25 12.5 12.5 25 34.8 
3j - 4-NO2 12.5 3.12 12.5 12.5 12.5 3.12 6.25 12.5 1.2 
3k - 4-N-(CH3)2 3.12 3.12 1.56 1.56 3.12 3.12 1.56 3.12 0.62 
3l - 3,4,5-(OCH3)3 >50 25 >50 25 >50 25 25 25 23.4 
3m - 3,4,-(OCH3)2 >50 >50 >50 25 25 >50 25 25 31.4 
3n - 4-OCH3 >50 25 25 >50 >50 >50 >50 >50 2.8 
3o - 4-Cl 3.12 6.25 3.12 6.25 3.12 12.5 6.25 3.12 0.83 
Ciprofloxacin  1.56 3.12 3.12 1.56 3.12 1.56 NA NA NA 
Ketoconazole  NA NA NA NA NA NA 1.56 3.12 NA 
Isoniazid   NA NA NA NA NA NA NA NA 0.56 
Key: * Mean values (n = 3);  BS - Bacillus subtilis; SA – Staphylococcus aureus; SM - Streptococcus mutants; EC - 
Escherichia coli; KP - Klebsiella pneumoniae; PA – Pseudomonas aeruginosa; CA - Candida albicans; AN - Aspergillus 
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and 3n exhibited moderate activity, while 
other compounds were less active. The 
antitubercular activity results correlated well 




The monocyclic 2-azetidinones, carbape-
nams and monobactams are active only 
against Gram-negative bacteria [23]. The 
synthesized compounds, however, showed 
about the same level of activity against both 
Gram-positive and Gram-negative bacteria. 
The results of antimicrobial activity and 
antitubercular activity revealed that 
compounds 3f, 3g, and 3o which have chloro 
substitution (electron withdrawing group) and 
3k which has para dimethyl amino (bulkier 
group) enhanced the activity of the 
azetidinones while the other groups, such as 
hydroxy, methoxy and nitro groups did not 
influence the activity. Among the chloro 
substituted compounds (3f, 3g, and 3o) 
compound 3g, which has a chloro group at 
meta position, exhibited the highest activity in 
the series. This suggests that electron 
withdrawing groups and bulkier groups are 
responsible for the activity. It is interesting to 
note that some of the currently used 
antitubercular drugs, such as pyrazinamide, 
isoniazid and ethionamide, also possess 
electron withdrawing groups as its 
pharmacophore. Further studies are going on 
in our laboratory to establish the quantitative 





This study indicates that the antimicrobial and 
antitubercular activities of the synthesized 
compounds can be attributed to the presence 
of 2-Cl, 3-Cl, 4-Cl and 4-N-(CH3)2 in phenyl 
ring at the fourth position of the azetidinone 
nucleus. The findings of this work should be 
helpful to medicinal chemists involved in 
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